ATE410175T1 - Co-perlchen von dha und rosmarin - Google Patents

Co-perlchen von dha und rosmarin

Info

Publication number
ATE410175T1
ATE410175T1 AT03718098T AT03718098T ATE410175T1 AT E410175 T1 ATE410175 T1 AT E410175T1 AT 03718098 T AT03718098 T AT 03718098T AT 03718098 T AT03718098 T AT 03718098T AT E410175 T1 ATE410175 T1 AT E410175T1
Authority
AT
Austria
Prior art keywords
pearls
rosemary
dha
Prior art date
Application number
AT03718098T
Other languages
English (en)
Inventor
John Lang
Yoav Blatt
Pavel Kazhdan
Rika Pinto
Oleg Safronchik
Original Assignee
Alcon Inc
Biodar Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Biodar Ltd filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE410175T1 publication Critical patent/ATE410175T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
AT03718098T 2002-03-28 2003-03-28 Co-perlchen von dha und rosmarin ATE410175T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36830102P 2002-03-28 2002-03-28

Publications (1)

Publication Number Publication Date
ATE410175T1 true ATE410175T1 (de) 2008-10-15

Family

ID=28675471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03718098T ATE410175T1 (de) 2002-03-28 2003-03-28 Co-perlchen von dha und rosmarin

Country Status (10)

Country Link
US (1) US20050106272A1 (de)
EP (1) EP1487469B1 (de)
JP (1) JP2005527559A (de)
AR (1) AR039170A1 (de)
AT (1) ATE410175T1 (de)
AU (1) AU2003222111A1 (de)
BR (1) BR0308799A (de)
CA (1) CA2479915A1 (de)
DE (1) DE60323947D1 (de)
WO (1) WO2003082313A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7239755B1 (en) * 1997-07-30 2007-07-03 Lg Electronics Inc. Method of reducing a blocking artifact when coding moving picture
ATE398445T1 (de) * 2002-03-28 2008-07-15 Alcon Inc Co-perlchen von dha und rosmarin und verwendungsverfahren
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US20070166354A1 (en) * 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US7829126B2 (en) * 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
EP3263101A1 (de) 2005-12-21 2018-01-03 Brudy Technology, S.L. Verwendung von dha, epa oder dha-abgeleitetes epa zur behandlung einer krankheitserscheinung im zusammenhang mit zelloxidationsschädigung
ES2277557B1 (es) * 2005-12-21 2008-07-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento del daño celular oxidativo.
EP1925302A1 (de) 2006-11-24 2008-05-28 DSMIP Assets B.V. Diätetische oder pharmazeutische Zubereitung enthaltend trizyklische Diterpene und ihre Derivate zur Behandlung von Depression
MX2009007701A (es) * 2007-01-19 2009-07-29 Iams Company Composicion y metodo de ingrediente sensible estabilizado.
MX2009007700A (es) * 2007-01-19 2009-07-29 Iams Company Composicion y metodo de ingrediente sensible estabilizado.
WO2008132713A1 (en) * 2007-04-29 2008-11-06 Shemen Industries Ltd. Nourishing oil composition for infants and young children
WO2009016091A1 (en) * 2007-08-01 2009-02-05 Unilever Plc Coated particles
US9445997B2 (en) 2007-12-21 2016-09-20 Basf Se Microcapsules comprising a fat-soluble active substance
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
WO2010074940A1 (en) 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
WO2010086235A1 (en) 2009-01-30 2010-08-05 Unilever Plc Oil-in-water emulsions
JP5560017B2 (ja) * 2009-10-13 2014-07-23 旭化成ケミカルズ株式会社 脂肪酸、トリグリセリドまたはその混合物を含むマルチコアマイクロカプセルを含有する錠剤およびその製法
WO2011057183A1 (en) 2009-11-06 2011-05-12 Alcon Research, Ltd. Nutritional supplements for relief of dry eye
MY166945A (en) 2010-12-31 2018-07-25 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
US8802650B2 (en) 2010-12-31 2014-08-12 Abbott Laboratories Methods of using human milk oligosaccharides for improving airway respiratory health
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
MY191538A (en) 2010-12-31 2022-06-30 Abbott Lab Human milk oligosaccharides to promote growth of beneficial bacteria
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
CA2822490C (en) 2010-12-31 2020-03-31 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
ES2667393T3 (es) 2010-12-31 2018-05-10 Abbott Laboratories Oligosacáridos de leche humana para modular inflamación
EP2734210B1 (de) 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharide zur prävention von verletzungen und/oder förderung der heilung des magen-darm-traktes
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
JP6178761B2 (ja) * 2013-07-10 2017-08-09 ライオン株式会社 内服剤
MX2017004582A (es) * 2014-10-08 2017-10-12 Abbott Lab Composiciones nutricionales que comprenden un componente oxidable y un extracto de plantas solubles en agua.
JP2019512029A (ja) * 2016-02-26 2019-05-09 ディーエスエム アイピー アセッツ ビー．ブイ．Ｄｓｍ Ｉｐ Ａｓｓｅｔｓ Ｂ．Ｖ． 新規コーティング系（ｉｉ）
CN105919946B (zh) * 2016-05-31 2019-03-12 福格森（武汉）生物科技股份有限公司 一种dha微丸的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
CH627449A5 (de) * 1977-03-25 1982-01-15 Hoffmann La Roche Verfahren zur herstellung von mikrokristallinem vitamin a-acetat, sowie von trockenen, frei-fliessenden praeparaten, in welchen vitamin a-acetat in mikrokristalliner form vorliegt.
IE52725B1 (en) * 1981-04-13 1988-02-03 Kuraray Co Method for production of formed food product of microfibrillar milk protein
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
US4670247A (en) * 1983-07-05 1987-06-02 Hoffman-Laroche Inc. Process for preparing fat-soluble vitamin active beadlets
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules
DK88692D0 (da) * 1992-07-06 1992-07-06 Danochemo As Fremgangsmaade til fremstilling af mikrokapsler
US6582721B1 (en) * 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US7097868B2 (en) * 2001-08-23 2006-08-29 Bio-Dar Ltd. Stable coated microcapsules
US7704542B2 (en) * 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
DE20205184U1 (de) * 2002-03-27 2002-12-19 Bartz, Volker, 35440 Linden Blutfettsenker zur oralen Einnahme
ATE398445T1 (de) * 2002-03-28 2008-07-15 Alcon Inc Co-perlchen von dha und rosmarin und verwendungsverfahren

Also Published As

Publication number Publication date
AU2003222111A1 (en) 2003-10-13
CA2479915A1 (en) 2003-10-09
DE60323947D1 (de) 2008-11-20
EP1487469B1 (de) 2008-10-08
BR0308799A (pt) 2007-01-09
EP1487469A4 (de) 2007-05-09
EP1487469A1 (de) 2004-12-22
US20050106272A1 (en) 2005-05-19
WO2003082313A1 (en) 2003-10-09
JP2005527559A (ja) 2005-09-15
AR039170A1 (es) 2005-02-09

Similar Documents

Publication Publication Date Title
DE60323947D1 (de) Co-perlchen von dha und rosmarin
DE60321669D1 (de) Co-perlchen von dha und rosmarin und verwendungsverfahren
DE60317799D1 (de) Antimikrobielle zusammensetzung und anwendungsverfahren
DE60326611D1 (de) N und dergleichen
ATE381347T1 (de) Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
DE60319810D1 (de) Anschwemmfiltermedien und herstellungs- und verwendungsverfahren
DE60332321D1 (de) Ultrafeine zusammensetzungen von formoterol
DE602005019461D1 (de) Orale zusammensetzungen mit extrakten von rosmarin und zugehörige verfahren
EP1581622A4 (de) Remodellierung und glycokonjugation von erythropoetin
DE60222671D1 (de) Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen
DE60335251D1 (de) Hocheffizienter medizinischer wandler von ergonomischer gestalt und herstellungsverfahren
DE60227301D1 (de) Strukturen von anschlusselementen und anzuschliessende komponente
DE60328206D1 (de) Scheibenwaschanlagendüse und scheibenwaschanlage
DE60216254D1 (de) Acrylkautschukzusammensetzung und vulkanisat
DE602004010708D1 (de) Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
ATE319308T1 (de) Kombinationen von cyclohexandionoxim-herbiziden und safeners
EP1499186A4 (de) Verwendung von häm-oxygenase-1 und häm-abbauprodukte
EP1377611A4 (de) Muteine des durch hypoxie induzierbaren faktors alpha und verwendungsverfahren dafür
DE60239896D1 (de) Velourskunstleder und seine herstellung
ATE476500T1 (de) Neue phospholipasen und deren verwendungen
DE60317639D1 (de) Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
PL361518A1 (pl) Zastosowanie substancji oraz kompozycja farmaceutyczna
DE60330255D1 (de) Thermoplastharzzusammensetzung und formkörper daraus
DE60320114D1 (de) Transformator und transformatoranordnung mit solchem transformator

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties